Delivery Order SPE2DB25D7056-SPE2DB25FTNDB
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $1,789.64, is for the delivery of 4,563,942,071 units of the pharmaceutical product Cephalexin 250 mg/5 ml suspension in 100 ml containers. This delivery order does not have a set-aside designation. The award is part of a larger, single-award indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,306.98, is for the delivery of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. The contract is a firm fixed-price delivery order with a period of performance ending on February 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,460.70, is for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml quantities. The contract has a July 12, 2024 completion date and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $3,462.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,110,399 units of Cephalexin 250 mg/5 ml suspension in 100 ml bottles. The delivery order, which does not have a set-aside designation, has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a fulfillment under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,609.79 to AmerisourceBergen Drug Corp for 500 mg Cephalexin capsules (500-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,757.20 firm fixed price contract is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. This order was placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides a broad range of pharmaceutical...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order valued at $7,761.23 to Amerisourcebergen Drug Corp, a global pharmaceutical sourcing and distribution company, to provide 4563556901 - Cephalexin 250 mg/5 ml suspension 100 ml. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,419.07 firm fixed-price delivery order covers the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication, with an ultimate completion date of August 16, 2023. The contract is not designated under a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,110.44, is for the delivery of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTNDBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,935.96 to AmerisourceBergen Drug Corp for the supply of Cephalexin 250 mg/5 mL suspension in 200 mL quantities. The award, issued on September 3, 2025, represents a firm fixed price, competitively awarded contract with an ultimate completion date of September 4, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and supply the antibiotic medication to support federal military and veteran healthcare systems. AmerisourceBergen Drug Corp's contract demonstrates the company's role as a critical vendor within the DLA's Medical Supply Chain, providing a comprehensive portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains. As a major for-profit pharmaceutical distributor registered in the System for Award Management, the company regularly fulfills delivery orders ranging from modest to substantial values through open competition. This particular award carries no set-aside designation and reflects AmerisourceBergen's established capability to meet federal procurement requirements for essential medications supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 9/3/25 |